Three Patients pp 177-186 | Cite as

Multiple Organ Failure and Intensive Care

  • Richard Burrows


“All is flux” (Heraclitus). There is no fine line that differentiates one action from another. Disease may be mild, moderate, severe, intractable, or irreversible, with no precise distinction between the various grades. Dying too is a process with no precise moment that divides alive from dead or when the process is irreversible as opposed to reversible.


Human Immunodeficiency Virus Multiple Organ Failure Human Immunodeficiency Virus Status Prospective Double Blind Study Emergency Medical Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A controlled trial to improve care for seriously ill hospitalized patients. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995;274:1591–8.Google Scholar
  2. 2.
    Klein G: Sources of Power: How People Make Decisions. Cambridge, MA: MIT Press, 1999.Google Scholar
  3. 3.
    George Bernard Shaw: The Doctor’s Dilemma. Edited by Landes W-A. Studio City, CA: Players Press, 1997.Google Scholar
  4. 4.
    Pellegrino ED: Rationing health care: the ethics of gatekeeping. J Contemp Health Law Policy 1986;2:23–45.Google Scholar
  5. 5.
    WHO World Health Report. December 1, 1999. Fig 99000-E-l.Google Scholar
  6. 6.
    TS v Minister of Health: Province of KwaZulu-Natal.Google Scholar
  7. 7.
    Hoffmann LJ, in Airedale NHS Trust v Bland: a judgement of the Court of Appeal, reported in (1993) All ER 821 at 857 B.Google Scholar
  8. 8.
    Levinsky NG: The doctor’s master. N Engl J Med 1984;311:1573–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Bhagwanjee S, Muckart DJ, Jeena PM, et al: Does HIV status influence the outcome of patients admitted to a surgical intensive care unit? A prospective double blind study. BMJ 1997;314:1077–84.PubMedCrossRefGoogle Scholar
  10. 10.
    Toon PD: After bioethics and towards virtue? J Med Ethics 1993;19:17–8.PubMedCrossRefGoogle Scholar
  11. 11.
    President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research: Deciding to Forego Life-Sustaining Treatment: A Report on the Ethical, Medical and Legal Issues in Treatment Decisions. Washington, DC: U.S. Government Printing Office, 1983.Google Scholar
  12. 12.
    Paris JJ, Reardon FE: Moral, ethical, and legal issues in the intensive care unit. J Intensive Care Med 1991;6:175–95.Google Scholar
  13. 13.
    Shade SG, Muslin H: Do not resuscitate decisions: discussions with relatives. J Med Ethics 1989;15:186–90.CrossRefGoogle Scholar
  14. 14.
    McIntyre RC, Pulido EJ, Bensard DD, et al: Thirty years of clinical trials in acute respiratory distress syndrome. Crit Care Med 2000;28:3314–31.PubMedCrossRefGoogle Scholar
  15. 15.
    South African Law Commission: Euthanasia and the Artificial Preservation of Life (Discussion Paper No 71, Project No 86). Pretoria, South Africa: South African Law Commission, 1998.Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Richard Burrows

There are no affiliations available

Personalised recommendations